Timing of fertility drug may affect egg quality in IVF

NCT ID NCT06511791

Terminated Disease control Sponsor: Ferring Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study looked at whether giving an extra fertility drug (FE 999302) at different times during ovarian stimulation could improve the number of good-quality embryos in women undergoing IVF. The trial included 106 women with high ovarian reserve and was stopped early. The main goal was to count good-quality blastocysts five days after egg retrieval.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY

Contacts and locations

Locations

Ferring Investigational Site

Brussels, 1090, Belgium
Ferring Investigational Site

Edegem, 2650, Belgium
Ferring Investigational Site

Prague, 150 00, Czechia
Ferring Investigational Site

Prague, 16000, Czechia
Ferring Investigational Site

Prague, 184 00, Czechia
Ferring Investigational Site

Copenhagen, 2100, Denmark
Ferring Investigational Site

Hvidovre, 2650, Denmark
Ferring Investigational Site

Bergen, 5006, Norway
Ferring Investigational Site

Porsgrunn, 3913, Norway
Ferring Investigational Site

Trondheim, 7042, Norway
Ferring Investigational Site

Barcelona, 08028, Spain
Ferring Investigational Site

Madrid, 28010, Spain
Ferring Investigational Site

Madrid, 28023, Spain
Ferring Investigational Site

Seville, 41092, Spain
Ferring Investigational Site

Valencia, 46015, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.